Trichoscan: what is new?
- PMID: 15983438
- DOI: 10.1159/000085581
Trichoscan: what is new?
Abstract
The treatment of androgenetic alopecia (AGA) is usually long lasting, and the effects of treatment attempts are difficult to measure. Consequently, there was a need for a sensitive tool to monitor hair loss and treatment response. Therefore, we developed the Trichoscan as a method which combines epiluminescence microscopy with automatic digital image analysis for the measurement of human hair. The Trichoscan is able to analyze all important parameters of hair growth (density, diameter, growth rate, vellus and terminal hair density) with an intraclass correlation of approximately 91% within the same Trichoscan operator and an intraclass correlation of approximately 97% for different Trichoscan operators. The application of the technique was demonstrated by comparison of the hair parameters in 9 men with frontal balding which were treated for 6 months with 5% minoxidil. Even in this small cohort of patients, we noticed after 3 months of treatment compared to baseline a significant increase in hair density (+21.3 hairs/cm2; p = 0.047) and cumulative hair thickness (+0.61 mm; p = 0.008) and after 6 months a significant increase in hair density (+34 hairs/cm2; p = 0.011) and cumulative hair thickness (+0.88 mm; p = 0.010). The study shows that the Trichoscan has many advantages. It can be used for clinical studies to compare placebo versus treatment or to compare the relative potencies of different hair-growth-promoting substances. It can be used for studying AGA or other forms of diffuse hair loss, and it can be adopted to study the effect of drugs or laser treatment on hypertrichosis or hirsutism. The drawbacks, however, are that the Trichoscan still needs a hair dye for contrast enhancement and the measurement area must be clipped before analysis. This mini-review summarizes recent attempts to optimize the technique and shows new options such as the calculation of follicular units or the 'anagen hair count'.
Copyright 2005 S. Karger AG, Basel.
Similar articles
-
TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.Eur J Dermatol. 2001 Jul-Aug;11(4):362-8. Eur J Dermatol. 2001. PMID: 11399546
-
[TrichoScan. A new instrument for digital hair analysis].Hautarzt. 2002 Dec;53(12):798-804. doi: 10.1007/s00105-002-0421-1. Hautarzt. 2002. PMID: 12444520 German.
-
TrichoScan: a novel tool for the analysis of hair growth in vivo.J Investig Dermatol Symp Proc. 2003 Jun;8(1):109-15. doi: 10.1046/j.1523-1747.2003.12183.x. J Investig Dermatol Symp Proc. 2003. PMID: 12895006 Clinical Trial.
-
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.Br J Dermatol. 2011 Dec;165 Suppl 3:12-8. doi: 10.1111/j.1365-2133.2011.10630.x. Br J Dermatol. 2011. PMID: 22171680 Review.
-
Hair loss in women.Semin Cutan Med Surg. 2009 Mar;28(1):19-32. doi: 10.1016/j.sder.2009.01.001. Semin Cutan Med Surg. 2009. PMID: 19341939 Review.
Cited by
-
Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study.Clin Cosmet Investig Dermatol. 2025 May 20;18:1239-1251. doi: 10.2147/CCID.S521215. eCollection 2025. Clin Cosmet Investig Dermatol. 2025. PMID: 40416946 Free PMC article.
-
Topical melatonin for treatment of androgenetic alopecia.Int J Trichology. 2012 Oct;4(4):236-45. doi: 10.4103/0974-7753.111199. Int J Trichology. 2012. PMID: 23766606 Free PMC article.
-
The Postpartum Telogen Effluvium Fallacy.Skin Appendage Disord. 2016 May;1(4):198-201. doi: 10.1159/000445385. Epub 2016 Apr 20. Skin Appendage Disord. 2016. PMID: 27386466 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous